v3.25.4
Supplementary Cash Flow Information (Tables)
12 Months Ended
Dec. 31, 2025
Supplementary Cash Flow Information  
Schedule of supplemental balance sheet disclosures

December 31, 2025

Unrestricted cash and cash

 

equivalents included in the

Cash and cash equivalents included on

consolidated statement of cash flows

Restricted cash and cash equivalents

the consolidated balance sheet

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

Cash

 

equivalents

Total

Cash

 

equivalents

Total

Cash

 

equivalents

Total

Holding company cash and investments

 

89.1

 

108.1

 

197.2

 

 

 

 

89.1

 

108.1

 

197.2

Subsidiary cash and short term investments

 

2,265.1

 

3,658.2

 

5,923.3

 

344.6

 

295.8

 

640.4

 

2,609.7

 

3,954.0

 

6,563.7

Fairfax India

 

17.4

 

0.4

 

17.8

 

 

4.2

 

4.2

 

17.4

 

4.6

 

22.0

Assets held for sale (note 21)

9.4

95.1

104.5

0.1

0.1

9.5

95.1

104.6

 

2,381.0

 

3,861.8

 

6,242.8

 

344.7

 

300.0

 

644.7

 

2,725.7

 

4,161.8

 

6,887.5

December 31, 2024

Unrestricted cash and cash 

 

equivalents  included in the 

Cash and cash equivalents included on 

consolidated statement  of cash flows

Restricted cash and cash equivalents

the consolidated balance sheet

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Cash

  ​ ​ ​

Cash

equivalents

Total

Cash

equivalents

Total

Cash

equivalents

Total

Holding company cash and investments

 

146.2

 

362.0

 

508.2

 

155.0

 

 

155.0

 

301.2

 

362.0

 

663.2

Holding company assets pledged for derivative obligations

 

 

101.1

 

101.1

 

 

 

 

 

101.1

 

101.1

Subsidiary cash and short term investments

 

2,411.2

 

3,010.2

 

5,421.4

 

1,000.1

 

240.6

 

1,240.7

 

3,411.3

 

3,250.8

 

6,662.1

Fairfax India

 

55.1

 

26.7

 

81.8

 

 

4.4

 

4.4

 

55.1

 

31.1

 

86.2

 

2,612.5

 

3,500.0

 

6,112.5

 

1,155.1

 

245.0

 

1,400.1

 

3,767.6

 

3,745.0

 

7,512.6

Schedule of cash flow, supplemental disclosures

Details of certain cash flows included in the consolidated statement of cash flows for the years ended December 31 were as follows:

  ​ ​ ​

2025

  ​ ​ ​

2024

Net (purchases) sales of investments classified at FVTPL

 

  ​

 

  ​

Short term investments

 

(1,268.6)

 

1,267.0

Bonds

 

(2,589.6)

 

(1,888.1)

Preferred stocks

 

(9.1)

 

(11.3)

Common stocks

 

(169.6)

 

(248.5)

Net derivatives and other invested assets

 

(22.2)

 

365.1

 

(4,059.1)

 

(515.8)

Changes in operating assets and liabilities

 

 

Net (increase) decrease in restricted cash and cash equivalents

 

746.5

 

(733.3)

Insurance contract receivables

(231.0)

144.2

Reinsurance contract assets held

(377.2)

17.2

Insurance contract payables

 

61.3

 

(273.8)

Insurance contract liabilities

4,329.4

2,388.4

Other receivables

 

62.9

 

(36.9)

Accounts payable and accrued liabilities

 

47.4

 

312.5

Other

 

(380.9)

 

(411.5)

 

4,258.4

 

1,406.8

Net interest and dividends received

 

 

Interest and dividends received

 

2,584.2

 

2,570.6

Interest paid on borrowings

 

(677.4)

 

(508.8)

Interest paid on lease liabilities

 

(73.0)

 

(57.3)

 

1,833.8

 

2,004.5

Net income taxes paid

 

(953.5)

 

(1,005.6)